Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions

Details for Australian Patent Application No. 2007316613 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Manuchehri, Alireza

Agent Davies Collison Cave

Pub. Number AU-A-2007316613

PCT Pub. Number WO2008/055940

Priority 60/865,099 09.11.06 US

Filing date 8 November 2007

Wipo publication date 15 May 2008

International Classifications

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/70 (2006.01) - Carbohydrates

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/055940 Priority application(s): WO2008/055940

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007316634-Dispensing head with hinged cap

2007316607-Amorphous form of N- {2-Fluoro-5-[3-(thiophene-2-carbonyl)-p yrazolo [1,5-a]pyrimidin-7-yl]-phenyl-N-methyl-a cetamide